Shackleton, C ; Czovek, D ; Grimwood, K ; Ware, RS ; Radics, B ; Hantos, Z ; Sly, PD

Defining "healthy' in preschool-aged children for forced oscillation technique reference equations

RESPIROLOGY 23 : 4 pp. 406-413. , 8 p. (2018)

Fabian, K ; Puskas, R ; Kakuk, T ; Pres, L ; Fejes, D ; Szegedi, Z ; Rojko, L ; Szallasi, Z ; Dome, B ; Pipek, O; Moldvay J

Renal Impairment Hampers Bisphosphonate Treatment in a Quarter of Lung Cancer Patients with Bone Metastasis

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY 122 : 1 pp. 126-132. , 7 p. (2018)

Sly, PD ; Shackleton, C ; Czovek, D ; Hantos, Z

Systematic Error in Respiratory Impedance Using Commercial Equipment Calibrated According to Manufacturer's Instructions

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 197 : 4 pp. 532-534. , 3 p. (2018)

Rojko, L ; Reiniger, L ; Teglasi, V ; Fabian, K ; Pipek, O ; Vagvolgyi, A ; Agocs, L ; Fillinger, J ; Kajdacsi, Z ; Timar, J; Dome, B; Szallasi, Z; Moldvay J

Chemotherapy treatment is associated with altered PD-L1 expression in lung cancer patients

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 144 : 7 pp. 1219-1226. , 8 p. (2018)

Moll, HP ; Pranz, K ; Musteanu, M ; Grabner, B ; Hruschka, N ; Mohrherr, J ; Aigner, P ; Stiedl, P ; Brcic, L ; Laszlo, V; Moldvay, J et al.

Afatinib restrains K-RAS-driven lung tumorigenesis

SCIENCE TRANSLATIONAL MEDICINE 10 : 446 Paper: eaao2301 , 12 p. (2018)

Zombori, T ; Nyári, T ; Tiszlavicz, L ; Pálföldi, R ; Csada, E ; Géczi, T ; Ottlakán, A ; Pécsy, B ; Cserni, G ; Furák, J

The more the micropapillary pattern in stage I lung adenocarcinoma, the worse the prognosis-a retrospective study on digitalized slides

VIRCHOWS ARCHIV 472 : 6 pp. 949-958. , 10 p. (2018)

Rich, A ; Baldwin, D ; Alfageme, I ; Beckett, P ; Berghmans, T ; Brincat, S ; Burghuber, O ; Corlateanu, A ; Cufer, T ; Damhuis, R; Moldvay J et al.

Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries

BMC CANCER 18 : 1 Paper: 1144 , 12 p. (2018)

Markoczy, Z ; Sarosi, V ; Kudaba, I ; Galffy, G ; Turay, UY ; Demirkazik, A ; Purkalne, G ; Somfay, A ; Papai-Szekely, Z ; Raso, E et al.

Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC): an open-label, non-randomized, multicenter, phase IV clinical trial

BMC CANCER 18 : 1 Paper: 598 , 7 p. (2018)

Ariel, A ; Altraja, A ; Belevskiy, A ; Boros, PW ; Danila, E ; Fležar, M ; Koblizek, V ; Fridlender, ZG ; Kostov, K ; Krams, A; Milenkovic, B; Somfay, A; Tkacova, R; Tudoric, N; Ulmeanu, R; Valipour A

Inhaled therapies in patients with moderate COPD in clinical practice: Current thinking

INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13 pp. 45-56. , 12 p. (2018)

Klikovits, T ; Lohinai, Z ; Fábián, K ; Gyulai, M ; Szilasi, M ; Varga, J ; Baranya, E ; Pipek, O ; Csabai, I ; Szállási, Z; Tímár, J; Hoda, MA; Laszlo, V; Hegedűs, B; Rényi-Vámos, F; Klepetko, V; Ostoros, Gy; Döme, B; Moldvay, J

New insights into the impact of primary lung adenocarcinoma location on metastatic sites and sequence: A multicenter cohort study

LUNG CANCER 126 pp. 139-148. , 10 p. (2018)

Ciuleanu, Tudor ; Socinski, Mark A ; Obasaju, Coleman ; Luft, Alexander V ; Szczesna, Aleksandra ; Szafranski, Wojciech ; Ramlau, Rodryg ; Balint, Beatrix ; Molinier, Olivier ; Depenbrock, Henrik et al.

Efficacy and Safety of Necitumumab Continuation Therapy in the Phase III SQUIRE Study of Patients With Stage IV Squamous Non-Small-Cell Lung Cancer

CLINICAL LUNG CANCER 19 : 2 pp. 130-138.e2. (2018)